Publications by authors named "Laura Davison"

Claim this Profile
P
Potency-optimized CD28-activating bispecific antibody for the targeted treatment of Nectin-4 positive cancers.
Manpreet Kaur, Katja Rüger, Elaine C Chen, Udaya S Rangaswamy, Laura M Davison

J Immunother Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ablation of SigH+ pDCs in B6.Nba2 mice prevents lupus-like disease development only if started before disease is fully established.
Nicole O Campbell, Laura M Davison, Shuvojit Banerjee, Jane K Nguyen, Sarah Krafcik

Lupus· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancer.
Brian C Avanzino, Kirthana Prabhakar, Pranjali Dalvi, Sharon Hartstein, Hannes Kehm, Laura M Davison

Oncoimmunology· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity.
Harshad S Ugamraj, Kevin Dang, Laure-Hélène Ouisse, Benjamin Buelow, Eduardo N Chini, Laura M Davison

MAbs· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHL.
Harbani K Malik-Chaudhry, Kirthana Prabhakar, Harshad S Ugamraj, Andrew A Boudreau, Benjamin Buelow, Laura M Davison

MAbs· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S100a9 Protects Male Lupus-Prone NZBWF1 Mice From Disease Development.
Laura M Davison, Andres A Alberto, Hardik A Dand, Emma J Keller, Madeline Patt

Front Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release.
Kevin Dang, Giulia Castello, Starlynn C Clarke, Yuping Li, Aarti Balasubramani, Laura Davison

J Immunother Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cells.
Katherine E Harris, Kyle J Lorentsen, Harbani K Malik-Chaudhry, Kaitlyn Loughlin, Harish Medlari Basappa, Laura M Davison

Sci Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited Effect of Indolamine 2,3-Dioxygenase Expression and Enzymatic Activity on Lupus-Like Disease in B6.Nba2 Mice.
Laura M Davison, Jessica C Liu, Lei Huang, Thomas M Carroll, Andrew L Mellor

Front Immunol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies.
Starlynn C Clarke, Biao Ma, Nathan D Trinklein, Ute Schellenberger, Michael J Osborn, Laura M Davison

Front Immunol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequence-Based Discovery Demonstrates That Fixed Light Chain Human Transgenic Rats Produce a Diverse Repertoire of Antigen-Specific Antibodies.
Katherine E Harris, Shelley Force Aldred, Laura M Davison, Heather Anne N Ogana, Andrew Boudreau

Front Immunol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engagement of private providers in immunization in the Western Pacific region.
Ananda Amarasinghe, Laura Davison, Sergey Diorditsa

Vaccine· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Treatments for Systemic Lupus Erythematosus on the Horizon: Targeting Plasmacytoid Dendritic Cells to Inhibit Cytokine Production.
Laura M Davison, Trine N Jorgensen

J Clin Cell Immunol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness of superficial subcutaneous lidocaine administration prior to femoral artery sheath removal.
Laura Davison, Anne McVety, Tara Oke

Nurs Leadersh (Tor Ont)· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sialic acid-binding immunoglobulin-type lectin H-positive plasmacytoid dendritic cells drive spontaneous lupus-like disease development in B6.Nba2 mice.
Laura M Davison, Trine N Jørgensen

Arthritis Rheumatol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of T cells in Act1-deficient mice results in elevated IgM-specific autoantibodies but reduced lupus-like disease.
Angela C Johnson, Laura M Davison, Natalia V Giltiay, Chairut Vareechon, Xiaoxia Li

Eur J Immunol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliability of Tanner stage assessments in a multi-center study.
Mark A Espeland, Dianne Gallagher, Grethe S Tell, Laura L Davison, Orah S Platt

Am J Hum Biol· January 1990

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis